Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib (INCB018424) in Myelofibrosis (COMFORT-I)
NCT00952289Phase 3Completed
- Sponsor
- Incyte
- Start
- Aug 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of ruxolitinib in myelofibrosis (MF), sponsored by Incyte. Started Aug 2009; status: completed.
02
Drugs
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00952289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952289.